Loading compliance resources…
Our analysis is not legal, medical, financial, tax, or regulatory advice. Read the original source and talk to a qualified professional before you act.
Our analysis is not legal, medical, financial, tax, or regulatory advice. Read the original source and talk to a qualified professional before you act.
We use Google Analytics, Vercel Web Analytics, and Vercel Speed Insights to improve the site. Select Decline to turn them off in this browser. We honor GPC and Do Not Track.
Read our Privacy Policy.
Federal rules, California add-ons and working tools, in one place
15
Risks Tracked
13
Reviewed rules
14
Case Studies
6
Compliance Domains
19 program requirements reviewed every 3 years during Operational Site Visits
ExploreData protection, breach response, BAA management, and workforce training
ExplorePPS billing rules, false claims prevention, 340B compliance, and coding audits
ExploreCalifornia sources on workplace injuries, claims, and risk mitigation
ExploreCalifornia credential requirements, licensing, and scope of practice
ExploreReady-to-use Excel spreadsheets — start your compliance work immediately.
Health centers should maintain one auditable request log with the received date, responsible owner, legal due date, extension notice if applicable, delivery format, completion date, and escalation status. Train the workforce on routing access requests immediately and review overdue and denied requests on a recurring cadence. These controls are a practical read-across from the corrective plan, not a claim that an FQHC engaged in the conduct.
Health centers should inventory manufacturer, specialty-pharmacy, advisory-board, speaker, and consulting arrangements; require fair-market-value review and written deliverables; verify that contracted data or adherence services were actually performed before payment; and prohibit gifts or hospitality tied to formulary, protocol, prescribing, or referral decisions. Open Payments reporting is the manufacturer's legal obligation in this case, but covered physicians should still review their public records and promptly dispute inaccuracies. These controls are a prudent read-across from the admitted conduct — not evidence that any FQHC engaged in it.
Do not read this as 340B stability. The ruling preserves the status quo on the mechanism while leaving the substantive question open and an HHS rebate pilot alive, which means a health center's 340B savings model still faces conversion risk on a timeline HHS controls. The concrete preparation is unglamorous: know whether your organization could operationally survive a rebate model — meaning whether you could fund full acquisition cost up front and produce claims-level data to substantiate rebate claims — and audit your patient-definition documentation and contract pharmacy agreements now, while the pressure is procedural rather than immediate.
The transferable lesson is a utilization-review prompt, not a payment rule. Health centers with behavioral health or medication-assisted treatment programs frequently have standing urine drug testing orders, and standing orders are exactly how simultaneous-panel patterns accumulate without anyone deciding to create them. Review whether any standing UDT order set produces multiple codes against one specimen on one date, and whether each test ordered is separately clinically justified and documented. NOTE ON BILLING SCOPE, DELIBERATELY: this entry makes no claim about what Medicare or Medicaid pays an FQHC for urine drug testing. FQHCs are reimbursed under a prospective payment system rather than the fee schedule at issue for a reference laboratory, and the DOJ release does not address health-center billing eligibility. Verify your own coding and payment questions with your MAC or state Medicaid program.
Explore career opportunities in compliance and operations. From entry-level analyst to Chief Compliance Officer.